Therapeutic protein selection in simulated in vivo conditions | Patent Publication Number 20230066527

US 20230066527 A1

Patent NumberUS 11879896 B2

Application Number17892618

Filled DateAug 22, 2022

Priority DateAug 13, 2018

Publication DateMar 2, 2023

Original AssigneeRegeneron Pharmaceuticals

Current AssigneeRegeneron Pharmaceuticals

Inventor/ApplicantsMichael Marlow
Dorothy Kim

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.